Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

U-41792

From Wikipedia, the free encyclopedia

U-41792
Identifiers
  • 1-[4-(1-adamantyloxy)phenyl]piperidine
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H29NO
Molar mass311.469 g·mol−1
3D model (JSmol)
  • C1CCN(CC1)C2=CC=C(C=C2)OC34CC5CC(C3)CC(C5)C4
  • InChI=1S/C21H29NO/c1-2-8-22(9-3-1)19-4-6-20(7-5-19)23-21-13-16-10-17(14-21)12-18(11-16)15-21/h4-7,16-18H,1-3,8-15H2
  • Key:NMFLMLJPBJHWSE-UHFFFAOYSA-N

U-41792 is a small molecule developed by the Upjohn Company as a hypobetalipoproteinemic agent, meaning it lowers levels of beta-lipoproteins, including low-density lipoprotein (LDL) such as apolipoprotein B, in the blood.[1] Elevated LDL levels can lead to early-onset atherosclerosis and increase the risk of heart problems.[2]

U-41792 demonstrated its ability to reduce lipid levels in hyperlipemic rats.[3][4][5]

Synthesis

[edit]

In order to synthesize U-41792, the alcohol of adamantane called 1-adamantanol is reacted with sodium to generate its corresponding alkoxide. This alkoxide then undergoes a nucleophilic aromatic substitution on p-fluoronitrobenzene to form the corresponding ether. This nitro group is then reduced and alkylated to give U-41792.[1]

References

[edit]
  1. 1 2 Lednicer D, Heyd WE, Emmert DE, TenBrink RE, Schurr PE, Day CE (January 1979). "Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline". Journal of Medicinal Chemistry. 22 (1): 69–77. doi:10.1021/jm00187a016. PMID 218007.
  2. Castañer J, Thorpe P (1979). "U-41792". Drugs of the Future. 4 (3): 223. doi:10.1358/dof.1979.004.03.1002424.
  3. Schurr PE, Day CE (January 1977). "Response to the hypobetalipoproteinemic agent adamantyloxyphenyl piperidine in hyperlipemic rats". Lipids. 12 (1): 22–28. doi:10.1007/BF02532967. PMID 189153.
  4. Day CE, Schurr PE, Heyd WE, Lednicer D (1976). "Biological activity of a hypobetalipoproteinemic agent". In Day DE (ed.). Advances in Experimental Medicine and Biology. Vol. 67. Springer US. pp. 231–249. doi:10.1007/978-1-4614-4618-7_14. ISBN 978-1-4757-9309-3. PMID 179296.
  5. Maxwell RE, Nawrocki JW, Uhlendorf PD (1978). "Effects of gemfibrozil (CI-719), gemcadiol (CI-720), clofibrate and U-41792 on cholesterol distribution in rat plasma fractions obtained by polyanion precipitation". Artery. 4 (4). Fulton, MI: 303–313.